Malaria
Data from Center for Disease Control and Prevention Advance Knowledge in Malaria
Published in TB and Outbreaks Week, May 1st, 2012
2012 MAY 1 -- "Cotrimoxazole prophylaxis prolongs survival and prevents opportunistic infections, malaria, and diarrhea in persons infected with human immunodeficiency virus (HIV). Many countries recommend that individuals taking antiretroviral therapy (ART) discontinue cotrimoxazole when CD4 counts are >200 cells/mu L. However, this practice has not been evaluated in sub-Saharan Africa," scientists writing in the journal Clinical Infectious Diseases report.
"Patients in the Home-Based AIDS Care program in eastern Uganda initiated ART if they had a CD4 cell count <= 250 cells/mu L or World Health Organization stage III or IV HIV disease. In the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Vaccines
New Vaccines Research Reported from National Autonomous University - Infectious Diseases
New Infectious Diseases Study Findings Have Been Published by Investigators at University of California - Tuberculosis
Investigators from University of Southern Florida Have Published New Data on Tuberculosis - Tuberculosis
Investigators at University of Utah Report Research in Tuberculosis - Clinical Trial Research
Investigators at Radboud University Detail Research in Clinical Trial Research - Tuberculosis
Data on Tuberculosis Described by Researchers at Fudan University - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
